Researchers at the University of Washington Medicine Retrovirology Lab at Harborview Medical Center in Seattle process samples from Novavax’s phase 3 COVID-19 vaccine clinical trial in February 2021. Karen Ducey/Getty Images hide caption toggle caption Karen Ducey/Getty Images Researchers at the University of Washington Medicine Retrovirology Lab at Harborview Medical Center in Seattle process samples